Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.66 USD
Change Today -0.05 / -1.85%
Volume 7.8K
BVX On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 8:04 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

bovie medical corp (BVX) Key Developments

Bovie Medical Corporation Announces Executive Changes

Bovie Medical Corporation announced that Peter L. Donato, Chief Financial Officer and Secretary of Bovie Medical Corporation, intends to resign from his service as Chief Financial Officer, Executive Vice President, Treasurer and Secretary of the Company on or about June 25, 2015. On June 15, 2015, the Board of Directors of the Company appointed Jay Ewers, currently the Controller of the Company, as the Interim Chief Financial Officer, Treasurer and Secretary of the Company effective upon Mr. Donato’s resignation. Mr. Ewers has more than 30 years of senior experience and has held financial executive positions in corporations ranging from early stage to high profile public companies with global operations in the medical equipment, manufacturing and semiconductor industries. He has extensive experience with Sarbanes Oxley, inventory management, Oracle modules and financial planning & analysis. Bovie Medical will engage an executive search firm to conduct a search for a permanent CFO.

Bovie Medical Corporation Hires Mark Charbonneau as J-Plasma Product Development Manager

Bovie Medical Corporation announced that it has hired Mark Charbonneau as J-Plasma Product Development Manager. Prior to joining the company, Mark was an engineering manager for Centrix and senior manufacturing engineer for Ventripoint Diagnostics. Mr. Charbonneau’s hire was effective May 18, 2015. He reports to Mr. Shawn Roman, Director of Research and Development.

Bovie Medical Corporation Announces Board Changes

Effective May 6, 2015, Ian Sheffield resigned from his position as a director of Bovie Medical Corporation. Mr. Sheffield's departure from the board was not the result of any disagreements with the company. Effective May 6, 2015, Charles T. Orsatti was appointed by the unanimous vote of the board of directors to the board of directors of the company to fill the vacancy created by Mr. Sheffield's departure. Mr. Orsatti was unanimously appointed to serve as vice chairman of the board of directors and shall also serve as chair of the compensation committee and member of the audit committee. Mr. Orsatti is a nominee of Great Point Partners, LLC pursuant to the terms of that certain Securities Purchase Agreement dated December 13, 2013 among the company and certain investors party thereto.

Bovie Medical Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

Bovie Medical reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company's sales were $6.1 million, a 5.5% decline from the $6.5 million reported in last year’s first quarter, as higher core product and J-Plasma® sales only partly offset the anticipated reduction in OEM revenues. Gross margin expanded to 43.6% from 42.5%. The Company had GAAP income of $12.9 million, or $0.57 per diluted share. This compares to GAAP loss of $9.8 million or $0.55 per diluted share in last year’s first quarter. Loss from operations was $2,272,000 compared to income from operations of $58,000 a year ago. Loss before income taxes was $868,000 compared to $9,569,000 a year ago. Net loss was $876,000 compared to $9,607,000 a year ago. Adjusted non-GAAP net loss was $2,542,000 or $0.14 per basic share compared to $212,000 or $0.01 per basic share a year ago.

Bovie Medical Corporation Presents at JMP Securities Life Sciences Conference, Jun-24-2015 11:30 AM

Bovie Medical Corporation Presents at JMP Securities Life Sciences Conference, Jun-24-2015 11:30 AM. Venue: The St. Regis New York, 2 East 55th Street, New York, NY 10022, United States. Speakers: Robert L. Gershon, Chief Executive Officer and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BVX:US $2.66 USD -0.05

BVX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
IRIDEX Corp $8.22 USD +0.26
MGC Diagnostics Corp $5.30 USD +0.04
Misonix Inc $8.81 USD -0.16
Stereotaxis Inc $1.49 USD +0.08
Synergetics USA Inc $4.77 USD +0.06
View Industry Companies
 

Industry Analysis

BVX

Industry Average

Valuation BVX Industry Range
Price/Earnings 11.0x
Price/Sales 1.8x
Price/Book 2.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BOVIE MEDICAL CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.